Teleflex Incorporated (NYSE:TFX) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC reduced its stake in shares of Teleflex Incorporated (NYSE:TFX) by 59.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 3,224 shares of the medical technology company’s stock after selling 4,802 shares during the period. Rice Hall James & Associates LLC’s holdings in Teleflex were worth $574,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Cromwell Holdings LLC increased its holdings in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after acquiring an additional 49 shares during the last quarter. Apollon Wealth Management LLC boosted its position in Teleflex by 3.7% during the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after acquiring an additional 55 shares during the period. SRS Capital Advisors Inc. lifted its holdings in shares of Teleflex by 0.3% in the third quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 60 shares during the period. Janney Montgomery Scott LLC lifted its holdings in shares of Teleflex by 0.4% in the third quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after buying an additional 66 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Mizuho cut their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial decreased their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Finally, Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Teleflex currently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Teleflex Price Performance

Shares of NYSE TFX opened at $169.33 on Wednesday. Teleflex Incorporated has a twelve month low of $165.62 and a twelve month high of $253.06. The business’s 50 day moving average price is $177.75 and its two-hundred day moving average price is $208.74. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a market cap of $7.86 billion, a PE ratio of 33.66, a price-to-earnings-growth ratio of 1.65 and a beta of 1.16.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.